-
1
-
-
0034158368
-
Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics
-
(2000)
Am J Ther
, vol.7
, pp. 63-74
-
-
Whelton, A.1
-
4
-
-
0025234906
-
Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
-
(1990)
Lancet
, vol.335
, pp. 765-774
-
-
MacMahon, S.1
Peto, R.2
Cutler, J.3
Collins, R.4
Sorlie, P.5
Neaton, J.6
Abbott, R.7
Godwin, J.8
Dyer, A.9
Stamler, J.10
-
7
-
-
0031983792
-
NSAIDs and blood pressure. Clinical importance for older patients
-
(1998)
Drugs Aging
, vol.12
, pp. 17-27
-
-
Johnson, A.G.1
-
8
-
-
0025347391
-
Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
-
(1990)
Lancet
, vol.335
, pp. 827-838
-
-
Collins, R.1
Peto, R.2
MacMahon, S.3
Hebert, P.4
Fiebach, N.H.5
Eberlein, K.A.6
Godwin, J.7
Qizilbash, N.8
Taylor, J.O.9
Hennekens, C.H.10
-
9
-
-
0025831464
-
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
-
(1991)
JAMA
, vol.265
, pp. 3255-3264
-
-
-
10
-
-
0033428385
-
Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition
-
(1999)
Am J Med
, vol.107
-
-
Brater, D.C.1
-
14
-
-
0032948948
-
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 735-741
-
-
Catella-Lawson, F.1
McAdam, B.2
Morrison, B.W.3
Kapoor, S.4
Kujubu, D.5
Antes, L.6
Lasseter, K.C.7
Quan, H.8
Gertz, B.J.9
FitzGerald, G.A.10
-
16
-
-
0034604272
-
Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial
-
(2000)
Ann Intern Med
, vol.133
, pp. 1-9
-
-
Swan, S.K.1
Rudy, D.W.2
Lasseter, K.C.3
Ryan, C.F.4
Buechel, K.L.5
Lambrecht, L.J.6
Pinto, M.B.7
Dilzer, S.C.8
Obrda, O.9
Sundblad, K.J.10
-
18
-
-
0035522319
-
High-normal blood pressure: More "high" than "normal"
-
(2001)
N Engl J Med
, vol.345
, pp. 1337-1339
-
-
Panza, J.A.1
-
23
-
-
0024456028
-
Aspirin lowers blood pressure in patients with renovascular hypertension
-
(1989)
Hypertension
, vol.14
, pp. 461-468
-
-
Imanishi, M.1
Kawamura, M.2
Akabane, S.3
Matsushima, Y.4
Kuramochi, M.5
Ito, K.6
Ohta, M.7
Kimura, K.8
Takamiya, M.9
Omae, T.10
-
32
-
-
0034707105
-
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
-
(2000)
N Engl J Med
, vol.343
, pp. 1520-1528
-
-
Bombardier, C.1
Laine, L.2
Reicin, A.3
Shapiro, D.4
Burgos-Vargas, R.5
Davis, B.6
Day, R.7
Ferraz, M.B.8
Hawkey, C.J.9
Hochberg, M.C.10
Kvien, T.K.11
Schnitzer, T.J.12
-
35
-
-
0034644396
-
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomised controlled trial. Celecoxib Long-term Arthritis Safety Study
-
(2000)
JAMA
, vol.284
, pp. 1247-1255
-
-
Silverstein, F.E.1
Faich, G.2
Goldstein, J.L.3
Simon, L.S.4
Pincus, T.5
Whelton, A.6
Makuch, R.7
Eisen, G.8
Agrawal, N.M.9
Stenson, W.F.10
-
37
-
-
0006452364
-
-
EULAR 2001; 13-16 June, 2001; Prague, Czech Republic. Abstract SAT0055
-
(2001)
Effect of rofecoxib, celecoxib, and naproxen on blood pressure and urinary sodium excretion in elderly volunteers
-
-
Schwartz, J.I.1
Malice, M.P.2
Lasseter, K.C.3
Holmes, G.B.4
Gottesdiener, K.M.5
Brune, K.6
-
38
-
-
0006413382
-
A comparison of rofecoxib to celecoxib and acetaminophen in the treatment of osteoarthritis
-
October 28-November 2, 2000; Boston, Massachusetts. Abstract 501
-
(2000)
The American College of Rheumatology 64th Annual Meeting
-
-
Geba, G.P.1
Weaver, A.L.2
Schnitzer, T.J.3
Fleischmann, R.M.4
Polis, A.B.5
Matzura-Wolfe, D.M.6
Dixon, M.E.7
Gormley, G.J.8
-
39
-
-
24944562342
-
-
EULAR 2001; June 13-16, 2001; Prague, Czech Republic. Abstract SAT0089
-
(2001)
Rofecoxib provides superior relief of symptoms of osteoarthritis (OA) compared to celecoxib
-
-
Schnitzer, T.J.1
Kivitz, A.J.2
Greenwald, M.3
Fleischman, R.M.4
Matzura-Wolfe, D.5
Polis, A.B.6
Dixon, M.E.7
Dobbins, T.W.8
Geba, G.P.9
|